Product Information
RIZATRIPTAN 5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3591 per EA under NDC 00093747143. Its NADAC has been published 648 times since Nov 28, 2013.
Strength
5 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093747143
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA077263On Market Since
2/12/2013
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG TABLET has been published 648 times since Nov 28, 2013, and over the history we have for it it has declined 76.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3591 per EA |
|---|---|
| All-time high | $1.9320 (Feb 12, 2014) |
| All-time low | $0.3203 (Jul 17, 2024) |
| 52-week high | $0.5666 |
| 52-week low | $0.3591 |
| Median price | $0.8163 |
| Average price | $0.8377 |
| Largest weekly change | +74.4% (Aug 21, 2024) |
| Weeks tracked | 648 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.3591 per EA (NDC 00093747143), effective Jun 24, 2026.
How has the price of RIZATRIPTAN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG TABLET has declined 76.6%. It has been tracked across 648 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG TABLET?
Since Nov 28, 2013, the NADAC for RIZATRIPTAN 5 MG TABLET has ranged from a low of $0.3203 (Jul 17, 2024) to a high of $1.9320 (Feb 12, 2014), with a median of $0.8163 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIZATRIPTAN 5 MG TABLET, is $0.3203 per EA — about 11% below RIZATRIPTAN 5 MG TABLET.
Who manufactures RIZATRIPTAN 5 MG TABLET?
RIZATRIPTAN 5 MG TABLET (NDC 00093747143) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification